Documentos relacionados

1. KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS.
2. Ribosome Collisions Trigger General Stress Responses to Regulate Cell Fate.
3. LXR agonists promote the proliferation of neural progenitor cells through MEK-ERK pathway.
4. Cell adhesion tunes inflammatory TPL2 kinase signal transduction.
5. Immunomodulatory Properties of BRAF and MEK Inhibitors Used for Melanoma Therapy-Paradoxical ERK Activation and Beyond.
6. A highly selective inhibitor of interleukin-1 receptor-associated kinases 1/4 (IRAK-1/4) delineates the distinct signaling roles of IRAK-1/4 and the TAK1 kinase.
7. Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells.
8. Interleukin-1 and TRAF6-dependent activation of TAK1 in the absence of TAB2 and TAB3.
9. TAK1 inhibition elicits mitochondrial ROS to block intracellular bacterial colonization.
10. Inflammatory Cytokine-Induced Muscle Atrophy and Weakness Can Be Ameliorated by an Inhibition of TGF-ß-Activated Kinase-1.